葡萄糖疾病 葡萄糖疾病
1Department of Family and Community Medicine Residency Program, Penn State Health-St. Joseph Hospital, 145 N. 6th Street, 2nd floor, Reading, PA 19601, USA.
Primary care
|July 27, 2024
概括
葡萄糖障碍,包括糖尿病,是常见的内分泌疾病,被视为一个频谱. 许多治疗方法针对不同的途径,为高血糖和低血糖提供全面的管理.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 主要护理医学 医疗保健
背景情况:
- 葡萄糖疾病代表了在初级保健中遇到的最常见的内分泌疾病.
- 这些情况往往重叠,表明了一种光谱,而不是不同的疾病.
- 复杂性需要一个细微的理解超越孤立的诊断.
研究的目的:
- 提供当前初级保健中葡萄糖疾病现状的概述.
- 突出糖尿病的各种疾病和可用的治疗策略.
- 讨论导致二次高血糖和低血糖的因素.
主要方法:
- 关于葡萄糖代谢和内分泌疾病的当前文献的综述.
- 对糖尿病治疗点的分析.
- 鉴定葡萄糖失调的次要原因.
主要成果:
- 糖尿病管理涉及针对葡萄糖生成,胰岛素敏感性,胰岛素分泌,脏葡萄糖分泌,碳水化合物吸收和隐素系统的多种药物.
- 二次性高血糖症或低血糖症可能是由各种内分泌条件,药物和生理压力引起的.
- 遗传酶缺陷占葡萄糖疾病的一小部分.
结论:
- 葡萄糖乱需要在初级保健中采用基于频谱的方法.
- 对糖尿病有广泛的药理干预措施,涉及多种病理生理路径.
- 识别二次原因和促成因素对于有效的葡萄糖管理至关重要.
相关概念视频
Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
Overview of Carbohydrate Metabolism
845
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
845
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Pathophysiology of Diabetes
913
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
913
Inborn Errors of Metabolism
150
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
150
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229


